TriMas (NASDAQ:TRS) Updates FY 2025 Earnings Guidance

TriMas (NASDAQ:TRS) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 1.700-1.850 for the period, compared to the consensus earnings per share estimate of 1.770. The company issued revenue guidance of $962.0 million-$980.5 million, compared to the consensus revenue estimate of $973.9 million.

TriMas Trading Up 11.2 %

Shares of TRS stock opened at $23.72 on Tuesday. The company has a market capitalization of $965.78 million, a price-to-earnings ratio of 36.68 and a beta of 0.55. TriMas has a twelve month low of $19.33 and a twelve month high of $28.51. The company has a current ratio of 2.83, a quick ratio of 1.44 and a debt-to-equity ratio of 0.60. The firm has a 50-day moving average price of $22.34 and a 200 day moving average price of $24.36.

TriMas (NASDAQ:TRS) last released its earnings results on Tuesday, April 29th. The industrial products company reported $0.46 EPS for the quarter, topping the consensus estimate of $0.43 by $0.03. TriMas had a net margin of 2.93% and a return on equity of 9.21%. Research analysts forecast that TriMas will post 1.69 earnings per share for the current fiscal year.

TriMas Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, May 13th. Investors of record on Tuesday, May 6th will be issued a $0.04 dividend. The ex-dividend date is Tuesday, May 6th. This represents a $0.16 dividend on an annualized basis and a yield of 0.67%. TriMas’s payout ratio is 27.12%.

Analyst Ratings Changes

Separately, BWS Financial reissued a “buy” rating and set a $40.00 price objective on shares of TriMas in a research note on Friday, February 28th.

Insider Transactions at TriMas

In related news, Director Shawn Sedaghat acquired 249,597 shares of TriMas stock in a transaction on Friday, March 7th. The shares were bought at an average price of $23.83 per share, for a total transaction of $5,947,896.51. Following the completion of the purchase, the director now directly owns 346,825 shares in the company, valued at $8,264,839.75. This trade represents a 256.71 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Jeffrey A. Fielkow purchased 2,500 shares of the firm’s stock in a transaction on Friday, February 28th. The stock was bought at an average price of $20.78 per share, with a total value of $51,950.00. Following the acquisition, the director now owns 11,013 shares in the company, valued at $228,850.14. This trade represents a 29.37 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders bought 806,246 shares of company stock worth $19,338,213. 14.20% of the stock is currently owned by company insiders.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.